Petitioner Tells High Court ‘Skinny Label’ Patent Ruling Could ‘Swallow’ Carve-Out
WASHINGTON, D.C. — In its Feb. 18 merits brief before the U.S. Supreme Court, a bioequivalent pharmaceutical maker argues that a patent holder’s complaint failed to state a claim for induced...To view the full article, register now.
Already a subscriber? Click here to view full article